10818532|t|Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia.
10818532|a|Factors accelerating cerebral degenerative changes represent potentially modifiable risks for cognitive decline. Putative risks accelerating subtle cognitive decline and dementia were correlated with repeated measures of cerebral atrophy, CT densitometry, perfusions, and cognitive testing among 224 neurologically and cognitively normative aging volunteers. After age 60, cerebral atrophy, ventricular enlargement, polioaraiosis, and leukoaraiosis geometrically increased as perfusions declined. Risks accelerating perfusional decline, cerebral atrophy, polioaraiosis, and leukoaraiosis were: transient ischemic attacks (TIAs), hypertension, smoking, hyperlipidemia, male gender. At age 71.5 +/- 11.9, subtle cognitive decline began, accelerated by TIAs, hypertension, and heart disease. Leukoaraiosis began before cognitive decline. TIAs, hypertension, and hyperlipidemia correlated with vascular dementias. Excessive cortical perfusional decreases and cerebral atrophy correlated with cognitive decline. Family history of neurodegenerative disease correlated with Alzheimer's disease. We concluded that TIAs, hypertension, hyperlipidemia, smoking, and male gender accelerate cerebral degenerative changes, cognitive decline, and dementia.
10818532	42	61	Alzheimer's disease	Disease	MESH:D000544
10818532	66	83	vascular dementia	Disease	MESH:D015140
10818532	106	135	cerebral degenerative changes	Disease	MESH:D019636
10818532	179	196	cognitive decline	Disease	MESH:D003072
10818532	233	250	cognitive decline	Disease	MESH:D003072
10818532	255	263	dementia	Disease	MESH:D003704
10818532	306	322	cerebral atrophy	Disease	MESH:D001284
10818532	458	474	cerebral atrophy	Disease	MESH:D001284
10818532	476	499	ventricular enlargement	Disease	MESH:D006332
10818532	501	514	polioaraiosis	Disease	
10818532	520	533	leukoaraiosis	Disease	MESH:D049292
10818532	622	638	cerebral atrophy	Disease	MESH:D001284
10818532	640	653	polioaraiosis	Disease	
10818532	659	672	leukoaraiosis	Disease	MESH:D049292
10818532	679	705	transient ischemic attacks	Disease	MESH:D002546
10818532	707	711	TIAs	Disease	MESH:D002546
10818532	714	726	hypertension	Disease	MESH:D006973
10818532	737	751	hyperlipidemia	Disease	MESH:D006949
10818532	795	812	cognitive decline	Disease	MESH:D003072
10818532	835	839	TIAs	Disease	MESH:D002546
10818532	841	853	hypertension	Disease	MESH:D006973
10818532	859	872	heart disease	Disease	MESH:D006331
10818532	874	887	Leukoaraiosis	Disease	MESH:D049292
10818532	901	918	cognitive decline	Disease	MESH:D003072
10818532	920	924	TIAs	Disease	MESH:D002546
10818532	926	938	hypertension	Disease	MESH:D006973
10818532	944	958	hyperlipidemia	Disease	MESH:D006949
10818532	975	993	vascular dementias	Disease	MESH:D015140
10818532	1040	1056	cerebral atrophy	Disease	MESH:D001284
10818532	1073	1090	cognitive decline	Disease	MESH:D003072
10818532	1110	1135	neurodegenerative disease	Disease	MESH:D019636
10818532	1152	1171	Alzheimer's disease	Disease	MESH:D000544
10818532	1191	1195	TIAs	Disease	MESH:D002546
10818532	1197	1209	hypertension	Disease	MESH:D006973
10818532	1211	1225	hyperlipidemia	Disease	MESH:D006949
10818532	1263	1292	cerebral degenerative changes	Disease	MESH:D019636
10818532	1294	1311	cognitive decline	Disease	MESH:D003072
10818532	1317	1325	dementia	Disease	MESH:D003704

